Chairman & Non-Executive Director
With over 30 years experience in stockbroking, investment and senior management with industrial corporations, Graham brings a wealth of management, finance and strategic planning experience to Device Technologies.
He was an Executive Director of the Armstrong Jones / Pacific Mutual Group from 1985 and Joint Managing Director from 1994 to 1997 when taken over by ING. He was previously Chairman of Aevum Limited until acquired by Stockland in 2010. Graham is currenty also Chairman of Heemskirk Consolidated Limited. He has a Batchelor of Economics degree from Sydney University.
Michael (Mick) Trevaskis
Chief Executive Officer
After graduating with a Bachelor of Health Sciences (Nursing), Mick commenced his medical career as a Registered Nurse in Melbourne gaining valuable clinical experience in his clinical specialty, Oncology. It was when Mick 4 years later, joined a family business in country Victoria that he developed a desire to pursue a career in business and sales.
In August 1998 Mick joined Device Technologies as an Orthopaedic Product Specialist for Victoria and Tasmania. He was quickly appointed to the position of Orthopaedic Product Manager and then National Business Manager Orthopaedics in August 1999.
In January 2003 he moved to Sydney to take up the position of National Sales Manager and in November 2006 became Director Sales and Marketing, with responsibility for the management of all sales and marketing activities undertaken by Device Technologies Group. In 2013 Mick was appointed to the Board of Directors at Device Technologies.
Mick has completed six years on the Board of the Medical Technology Association of Australia with two of these years serving as Treasurer.
Mick has continued add to his qualifications by completing his Company of Directors course at AICD in 2014 and followed that later on in the year by graduating from the Advanced Management Programme at INSEAD in Fontainebleau, France.
Mick’s 18 year tenure at Device Technologies across many senior management positions has him well placed to lead the company into the future.
Executive Director / Chief Operating Officer
Emma joined Device Technologies as CFO in December 2005 after more than fifteen years experience in the finance and accounting field. She has worked extensively in the professional firm environment and overseas for a number of large multinational companies, specialising in acquisitions, business development and delivering change across organisations.
Emma’s broad commercial and international experience help shape the future growth and security of the Device Technologies Group of companies. Key areas of responsibility include financial control, supply chain management, administration and IT.
Kevin brings over thirty (30) years of specialty healthcare sales, marketing and management experience to the company. Kevin has a diverse knowledge of the key areas of public and private healthcare in the region and of the market forces and dynamics which prevail.
With key relationships throughout many specialty faculties, he enjoys the respect and loyalty of the medical and surgical community. Kevin’s knowledge and understanding of the ever-changing healthcare market has been instrumental in the introduction of many new technologies and advances.
Having served on the Board of the industry association (MTAA) for 8 years, he continues to forge the avenue of change for technology access, device reimbursement and most importantly, improved patient outcomes.
Working alongside his business partners and loyal staff, Kevin has helped build Device Technologies into Australasia’s largest independent medical device company.
With over forty years of marketing and sales experience in the USA, UK and Australia, Peter’s detailed knowledge of both the multi-national and entrepreneurial healthcare business, provides complementary results for the Device Technologies Group of companies.
His marketing background guarantees that the management of the company is directed towards customer needs and customer satisfaction. His international contacts ensure the company is at the forefront of healthcare technology, with state of the art medical and surgical devices.
Peter has assembled an executive management team that reflects his own experience and interests in the provision of advanced healthcare solutions.
Magnus joined RMB Capital Partners from Cinven, a leading European private equity fund, where he was based in London and responsible for the Nordic region. At Cinven he completed investments in the business services, healthcare and industrials sectors.
Prior to Cinven, Magnus was at Intermediate Capital Group, a global alternative asset manager. At ICG he established the Stockholm office and ran the Nordic investment business. During this time Magnus completed transactions in a variety of sectors including consumer, healthcare, media and telecommunications.
Magnus started his career at Nomura with the investment banking team and then moved into private equity focusing on investments in emerging markets. Part of his time at Nomura was spent on secondment to one of the investee companies.
Magnus is a Director of Placard, Device Technologies, HMG, NDA and HR3.
Robert (Rob) Scherini
Rob is a past Managing Director for Johnson & Johnson Medical Australia/NZ and has held senior management positions both locally and internationally. He has a strong track record of growing businesses and brings to the Board a wealth of experience in Sales & Marketing, Business Development, Finance, Operations and Supply, Legal, Human Resources and Information Technology.
Rob is a Certified Practising Accountant (CPA) and was a Member of the Board of the Medical Technology Association of Australia (MTAA) for nine years. He has been a strong advocate of Human Resources Strategy and was recognised as Best HR Champion at the 2004 Australian HR Awards. In 2007 was awarded a Rotary International Fellowship for his assistance to the community.
More recently Rob has devoted his time to consulting and mentoring. He remains a Board member of a listed health care company and Senior Partner of a healthcare consulting practice. He is also a member of the Executive Advisory Council of the Faculty of Health at the University of Technology, Sydney (UTS).
A 1987 graduate of Cambridge University, Mark spent 7 years at Bain and Company, London, before his appointment to lead assignments for large European companies in the FMCG, financial services, telecoms and industrial sectors.
In 1996, with the backing of leading US private equity firm, Bain Capital, Mark co-founded the private equity partnership, SB Capital Partners and set about working on buy-out transactions. He returned to London in 1997 to set up and build out the investment sourcing and evaluation network across Europe. On the back of this success Bain Capital launched its first dedicated European buy-out fund.
During this time Mark assisted one of the partners (Norwegian company, Smedvig) to build up its own portfolio of private equity investments and in 2001 he joined Smedvig Capital as a Managing Director and one of the senior executives responsible for investing, managing and reporting on a diversified A$350m private equity portfolio.
Mark is married to an Australian and in 2006 moved to Australia with his family before taking up his position as a Partner at RMB. He is Chairman of Placard Pty Ltd and a Director of Interiorco, Ausreo and Instant Access.